RIBAVIRIN CAPSULES

Manufacturer: Zydus Lifesciences Limited
Effective date: 2024-12-04
Label type: HUMAN PRESCRIPTION DRUG LABEL
Version: 9
Source: legacy-cache
Hydrated at: 2026-08-01 20:47:32

Label at a glance#

ProductRibavirin

Active ingredientRIBAVIRIN

Label structure1 sections

Label contents#

Full prescribing information#

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 65841-260-12 in bottle of 84 capsules

Ribavirin Capsules USP, 200 mg

R_xonly

84 capsules

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
RIBAVIRIN	ACTIVE INGREDIENT	49717AWG6K	1
RIBAVIRIN	ACTIVE MOIETY	49717AWG6K	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	1
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	1
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

Ribavirin
CROSPOVIDONE (15 MPA.S AT 5%)
MAGNESIUM STEARATE
GELATIN
POVIDONE
TITANIUM DIOXIDE
SILICON DIOXIDE
CELLULOSE, MICROCRYSTALLINE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
65841-260	65841-260-30, 65841-260-04, 65841-260-07, 65841-260-09, 65841-260-12, 65841-260-13, 65841-260-03, 65841-260-28, 65841-260-10

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
RIBAVIRIN	49717AWG6K	ACTIB
CROSPOVIDONE (15 MPA.S AT 5%)	68401960MK	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
GELATIN	2G86QN327L	IACT
POVIDONE	FZ989GH94E	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 230 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	FILM, SOLUBLE / ORAL		2 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, DELAYED RELEASE / ORAL		144 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	GRANULE, FOR SUSPENSION / ORAL		143 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	INSERT / VAGINAL		8 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, DELAYED RELEASE / ORAL		66 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE / ORAL	5000 mg		Exact identifier — unii candidate 49 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	TABLET, FILM COATED / ORAL		57 mg	Exact identifier — unii candidate 44 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE, EXTENDED RELEASE / ORAL		117 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CREAM / TOPICAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	SUSPENSION, EXTENDED RELEASE / ORAL		71 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GEL / TOPICAL		6 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	SYSTEM / TRANSDERMAL		35 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	CAPSULE / ORAL		10932 mg	Exact identifier — unii candidate 44 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	GRANULE / ORAL		629 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE, DELAYED RELEASE / ORAL		1060 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	SUPPOSITORY / RECTAL	14 mg		Exact identifier — unii candidate 49 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	CAPSULE, COATED / ORAL		288 mg	Exact identifier — unii candidate 44 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	PELLET / ORAL		1140 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	DROPS / ORAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER / RESPIRATORY (INHALATION)	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, FOR SUSPENSION / ORAL		200 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TROCHE / ORAL		300 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
POVIDONE	POVIDONE	FZ989GH94E	TABLET, EXTENDED RELEASE / ORAL		101 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	POWDER, FOR SUSPENSION / ORAL		297 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	CAPSULE, COATED PELLETS / ORAL		456 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
POVIDONE	POVIDONE	FZ989GH94E	TABLET, CHEWABLE / ORAL		48 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	IMPLANT / SUBCUTANEOUS	0.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER, FOR SUSPENSION / ORAL		2553 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER / ORAL		602 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR		2 mg	Exact identifier — unii candidate 44 equally ranked IID candidates
POVIDONE	POVIDONE	FZ989GH94E	TROCHE / ORAL	30 mg		Exact identifier — unii candidate 30 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	POWDER, FOR SUSPENSION / ORAL	NA		Exact identifier — unii candidate 44 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 44 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, COATED / ORAL		176 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	LOZENGE / ORAL		420 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
POVIDONE	POVIDONE	FZ989GH94E	IMPLANT / SUBCUTANEOUS	6 mg		Exact identifier — unii candidate 30 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	CAPSULE, DELAYED RELEASE / ORAL		366 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 44 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, EXTENDED RELEASE / ORAL		450 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	CAPSULE, EXTENDED RELEASE / ORAL		67 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	PASTE / DENTAL		252 mg	Exact identifier — unii candidate 44 equally ranked IID candidates
POVIDONE	POVIDONE	FZ989GH94E	CAPSULE, DELAYED RELEASE / ORAL	NA		Exact identifier — unii candidate 30 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 40 equally ranked IID candidates
POVIDONE	POVIDONE	FZ989GH94E	DROPS / ORAL	NA		Exact identifier — unii candidate 30 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR		1 mg	Exact identifier — unii candidate 44 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	TABLET / ORAL		232 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GEL / DENTAL	19 %w/w		Exact identifier — unii candidate 49 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	TABLET, DELAYED RELEASE / ORAL	19 mg		Exact identifier — unii candidate 44 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	PELLET / ORAL		34 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, DELAYED RELEASE PARTICLES / ORAL		170 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE / ORAL		300 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	DROPS / ORAL	NA		Exact identifier — unii candidate 44 equally ranked IID candidates
POVIDONE	POVIDONE	FZ989GH94E	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		350 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	OINTMENT / TOPICAL	5 %w/w		Exact identifier — unii candidate 40 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	LOZENGE / ORAL		120 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		69 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER / TOPICAL		104 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
GELATIN	GELATIN	2G86QN327L	INJECTION, SUSPENSION / INTRAMUSCULAR	1.3 mg		Exact identifier — unii candidate 44 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		53 mg	Exact identifier — unii candidate 39 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077224-001	RIBAVIRIN	RIBAVIRIN	200MG	CAPSULE / ORAL	AB		2005-10-28

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A077224-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A077224-001	RIBAVIRIN	200MG	CAPSULE / ORAL	AB	2005-10-28	`f41ea6bd6efb…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A077224-001	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A077224-001	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077224-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077224-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077224-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077224-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077224-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077224-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077224-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077224-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077224-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077224-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077224-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077224-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077224-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077224-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077224-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077224-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077224-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077224-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077224-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A077224-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A077224-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A077224-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A077224-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A077224-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A077224-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A077224-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A077224-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A077224-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A077224-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A077224-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A077224-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A077224-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A077224-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A077224-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A077224-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A077224-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A077224-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A077224-001	AB	1	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
8a217fa5-15ac-4746-9c24-3070b6161649			b97cd49c-9e19-4a35-987c-06e62bb25b6b	2025-05-09		Exact identifier spl set id: b97cd49c-9e19-4a35-987c-06e62bb25b6b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.